Experimental virus therapy tested for Hard-to-Treat breast cancer
Disease control
Completed
This early-phase study tested a new drug made from a modified virus in 34 women with advanced breast cancer that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the highest dose that doesn't cause severe side effects. The drug …
Phase: PHASE1 • Sponsor: "Oncostar" LLC • Aim: Disease control
Last updated May 06, 2026 16:01 UTC